These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 12763085)

  • 1. Blockade of ventral pallidal opioid receptors induces a conditioned place aversion and attenuates acquisition of cocaine place preference in the rat.
    Skoubis PD; Maidment NT
    Neuroscience; 2003; 119(1):241-9. PubMed ID: 12763085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the selective mu(1)-opioid receptor antagonist, naloxonazine, on cocaine-induced conditioned place preference and locomotor behavior in rats.
    Rademacher DJ; Steinpreis RE
    Neurosci Lett; 2002 Nov; 332(3):159-62. PubMed ID: 12399005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of ethanol responding by centrally administered CTOP and naltrindole in AA and Wistar rats.
    Hyytiä P; Kiianmaa K
    Alcohol Clin Exp Res; 2001 Jan; 25(1):25-33. PubMed ID: 11198711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (+)-Morphine attenuates the (-)-morphine-produced conditioned place preference and the mu-opioid receptor-mediated dopamine increase in the posterior nucleus accumbens of the rat.
    Terashvili M; Wu HE; Schwasinger ET; Hung KC; Hong JS; Tseng LF
    Eur J Pharmacol; 2008 Jun; 587(1-3):147-54. PubMed ID: 18448094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A role for mu opioid receptors in cocaine-induced activity, sensitization, and reward in the rat.
    Schroeder JA; Hummel M; Simpson AD; Sheikh R; Soderman AR; Unterwald EM
    Psychopharmacology (Berl); 2007 Dec; 195(2):265-72. PubMed ID: 17687547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mu-opioid receptor antagonist D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2 (CTOP) [but not D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 (CTAP)] produces a nonopioid receptor-mediated increase in K+ conductance of rat locus ceruleus neurons.
    Chieng B; Connor M; Christie MJ
    Mol Pharmacol; 1996 Sep; 50(3):650-5. PubMed ID: 8794906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cocaine-induced reinstatement requires endogenous stimulation of mu-opioid receptors in the ventral pallidum.
    Tang XC; McFarland K; Cagle S; Kalivas PW
    J Neurosci; 2005 May; 25(18):4512-20. PubMed ID: 15872098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Place aversion induced by blockade of mu or activation of kappa opioid receptors in the dorsal periaqueductal gray matter.
    Sante AB; Nobre MJ; Brandão ML
    Behav Pharmacol; 2000 Nov; 11(7-8):583-9. PubMed ID: 11198129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Naloxone fails to produce conditioned place aversion in mu-opioid receptor knock-out mice.
    Skoubis PD; Matthes HW; Walwyn WM; Kieffer BL; Maidment NT
    Neuroscience; 2001; 106(4):757-63. PubMed ID: 11682161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cocaine reward and hyperactivity in the rat: sites of mu opioid receptor modulation.
    Soderman AR; Unterwald EM
    Neuroscience; 2008 Jul; 154(4):1506-16. PubMed ID: 18550291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens.
    Hirose N; Murakawa K; Takada K; Oi Y; Suzuki T; Nagase H; Cools AR; Koshikawa N
    Neuroscience; 2005; 135(1):213-25. PubMed ID: 16111831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central administration of nociceptin/orphanin FQ blocks the acquisition of conditioned place preference to morphine and cocaine, but not conditioned place aversion to naloxone in mice.
    Sakoori K; Murphy NP
    Psychopharmacology (Berl); 2004 Mar; 172(2):129-36. PubMed ID: 14624329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nucleus accumbens μ-opioid receptors mediate social reward.
    Trezza V; Damsteegt R; Achterberg EJ; Vanderschuren LJ
    J Neurosci; 2011 Apr; 31(17):6362-70. PubMed ID: 21525276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential conditioned place preference responses to endomorphin-1 and endomorphin-2 microinjected into the posterior nucleus accumbens shell and ventral tegmental area in the rat.
    Terashvili M; Wu HE; Leitermann RJ; Hung KC; Clithero AD; Schwasinger ET; Tseng LF
    J Pharmacol Exp Ther; 2004 May; 309(2):816-24. PubMed ID: 14755004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Buprenorphine and a CRF1 antagonist block the acquisition of opiate withdrawal-induced conditioned place aversion in rats.
    Stinus L; Cador M; Zorrilla EP; Koob GF
    Neuropsychopharmacology; 2005 Jan; 30(1):90-8. PubMed ID: 15138444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Constitutively active micro opioid receptors mediate the enhanced conditioned aversive effect of naloxone in morphine-dependent mice.
    Shoblock JR; Maidment NT
    Neuropsychopharmacology; 2006 Jan; 31(1):171-7. PubMed ID: 15956992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNQX in the nucleus accumbens inhibits cocaine-induced conditioned place preference.
    Kaddis FG; Uretsky NJ; Wallace LJ
    Brain Res; 1995 Oct; 697(1-2):76-82. PubMed ID: 8593597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockade of mu-opioid receptors reveals the hyperalgesic effect of orphanin FQ/nociceptin in the rat hot plate test.
    Lutfy K; Maidment NT
    Br J Pharmacol; 2000 Dec; 131(8):1684-8. PubMed ID: 11139447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endomorphin-2 and endomorphin-1 promote the extracellular amount of accumbal dopamine via nonopioid and mu-opioid receptors, respectively.
    Okutsu H; Watanabe S; Takahashi I; Aono Y; Saigusa T; Koshikawa N; Cools AR
    Neuropsychopharmacology; 2006 Feb; 31(2):375-83. PubMed ID: 16034447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fentanyl increases dopamine release in rat nucleus accumbens: involvement of mesolimbic mu- and delta-2-opioid receptors.
    Yoshida Y; Koide S; Hirose N; Takada K; Tomiyama K; Koshikawa N; Cools AR
    Neuroscience; 1999; 92(4):1357-65. PubMed ID: 10426490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.